Moderna CEO brazenly defends 400% COVID shot price hike, downplays NIH’s role
Published
Sen. Sanders accused the company of an "unprecedented level of corporate greed."
Full ArticlePublished
Sen. Sanders accused the company of an "unprecedented level of corporate greed."
Full ArticleModerna Inc (NASDAQ: MRNA) has been in focus recently after revealing plans of raising price of its COVID shot by a staggering..
Before a Senate panel, Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price.